Clinical Trials Sponsored by Horizon Therapeutics USA, Inc.
Total 57 results
-
Horizon Therapeutics USA, Inc.CompletedThyroid Eye Disease | Chronic (Inactive) Thyroid Eye DiseaseUnited States
-
Horizon Therapeutics USA, Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States
-
Horizon Pharma USA, Inc.Completed
-
Horizon Pharma USA, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Horizon Pharma USA, Inc.CompletedAldehyde Dehydrogenase-2 (ALDH2) DeficiencyUnited States
-
Horizon Pharma USA, Inc.Recruiting
-
Horizon Pharma USA, Inc.CompletedThyroid-Associated Ophthalmopathy | Thyroid Associated OphthalmopathiesUnited Kingdom, United States, Germany, Italy
-
Horizon Pharma USA, Inc.CompletedCystic Fibrosis (CF)Germany, United States, Netherlands
-
Horizon Pharma USA, Inc.CompletedCystic FibrosisUnited States
-
Horizon Pharma USA, Inc.CompletedInherited Mitochondrial Disease, Including Leigh SyndromeUnited States
-
Horizon Pharma USA, Inc.CompletedThyroid Eye Disease | Graves' OrbitopathyUnited States, Italy, Germany
-
Horizon Pharma USA, Inc.CompletedThyroid Eye DiseaseItaly, United States, Germany
-
Horizon Pharma USA, Inc.Approved for marketingThyroid Eye Disease | Graves' OrbitopathyUnited States
-
Horizon Pharma USA, Inc.CompletedCystinosisFrance, United States, United Kingdom, Belgium, Italy, Netherlands
-
Horizon Pharma USA, Inc.CompletedCystinosisFrance, United States, Netherlands
-
Horizon Pharma USA, Inc.Terminated
-
Horizon Pharma USA, Inc.CompletedCystic FibrosisUnited States
-
Horizon Pharma USA, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Horizon Pharma USA, Inc.CompletedCystinosisFrance, United States, Netherlands
-
Horizon Pharma USA, Inc.Completed
-
Horizon Pharma USA, Inc.Forest LaboratoriesCompletedCystic FibrosisUnited States, Australia, Israel, New Zealand, Canada
-
Horizon Pharma USA, Inc.Forest LaboratoriesCompletedTrial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients (TIS)Cystic FibrosisUnited States, Ireland, United Kingdom, France, Germany, Israel
-
University of PittsburghHorizon Pharma USA, Inc.RecruitingUndiagnosed DiseaseUnited States
-
Knight Therapeutics (USA) IncRecruitingLeishmaniasis or Other Uses of MiltefosineUnited States
-
Knight Therapeutics (USA) IncCompletedCutaneous Leishmaniasis | Mucosal LeishmaniasisUnited States
-
Knight Therapeutics (USA) IncWithdrawnLeishmaniasisUnited States
-
Knight Therapeutics (USA) IncCompletedMucocutaneous LeishmaniasisBolivia
-
Orum Therapeutics USA, Inc.RecruitingHER2-positive Breast Cancer | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionUnited States
-
Knight Therapeutics (USA) IncCompletedMucocutaneous LeishmaniasisBolivia
-
Sawa Ito, MDHorizon Pharma USA, Inc.CompletedMyelodysplastic Syndromes | Myeloid Leukemia | Allogeneic Stem Cell TransplantationUnited States
-
Millendo Therapeutics US, Inc.TerminatedCongenital Adrenal HyperplasiaSpain, Israel, France, Brazil, Czechia
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Horizon Pharma USA, Inc.TerminatedMyxoid Liposarcoma | Synovial Sarcoma | Round Cell LiposarcomaUnited States
-
Millendo Therapeutics US, Inc.TerminatedCushing SyndromeUnited States, United Kingdom
-
Ottawa Hospital Research InstituteKnight Therapeutics (USA) IncRecruiting
-
Skyline Therapeutics (US) Inc.RecruitingNeovascular Age-related Macular DegenerationUnited States
-
Millendo Therapeutics US, Inc.Covance; Medpace, Inc.Terminated
-
AffaMed Therapeutics (US) Inc.RecruitingNeovascular Age-related Macular DegenerationUnited States
-
Nykode Therapeutics ASAGenentech, Inc.; Vaccibody ASRecruitingSolid Tumors, AdultUnited States, Spain, Germany
-
US Oncology ResearchKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Plasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Kahler Disease | Myeloma, Plasma Cell | MyelomatosisUnited States
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaKorea, Republic of, United States, Belgium, Spain, Taiwan, China, United Kingdom, France, Canada, Germany, Thailand, Italy, Portugal, Australia, Puerto Rico
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedUpper Tract Urothelial Carcinomas | Urothelial Bladder CancerUnited States, France, Canada, Spain, Italy, Belgium, Germany, Netherlands, United Kingdom, Bulgaria, Greece
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaUnited States, Belgium, Germany, Italy, Korea, Republic of, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Peloton Therapeutics, Inc., a subsidiary of Merck...Active, not recruitingKidney Cancer | Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | ccRCC | RCCUnited States
-
Peloton Therapeutics, Inc., a subsidiary of Merck...Active, not recruitingVHL - Von Hippel-Lindau Syndrome | VHL Gene Mutation | VHL Syndrome | VHL Gene Inactivation | VHL-Associated Renal Cell Carcinoma | VHL-Associated Clear Cell Renal Cell CarcinomaUnited States, Denmark, United Kingdom, France
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompleted
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompleted
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompletedHuman Immunodeficiency Virus (HIV)United States, Puerto Rico
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompleted
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompleted
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompleted